107 related articles for article (PubMed ID: 20306248)
21. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
Pabst T; Mueller BU
Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
[TBL] [Abstract][Full Text] [Related]
22. Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue T; Tamura T; Ozato K
Int Rev Immunol; 2001 Feb; 20(1):83-105. PubMed ID: 11342299
[TBL] [Abstract][Full Text] [Related]
23. Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
Salomé M; Hopcroft L; Keeshan K
Exp Hematol; 2018 Oct; 66():63-78.e13. PubMed ID: 30031847
[TBL] [Abstract][Full Text] [Related]
24. On the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver.
Benetatos L; Vartholomatos G
Ann Hematol; 2016 Oct; 95(10):1571-82. PubMed ID: 26983918
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs: new players in AML pathogenesis.
Nicoloso MS; Jasra B; Calin GA
Cancer Treat Res; 2010; 145():169-81. PubMed ID: 20306251
[No Abstract] [Full Text] [Related]
26. Proteomic analysis of transcription factor interactions in myeloid stem cell development and leukaemia.
Behre G; Reddy VA; Tenen DG; Hiddemann W; Zada AA; Singh SM
Expert Opin Ther Targets; 2002 Aug; 6(4):491-5. PubMed ID: 12223063
[TBL] [Abstract][Full Text] [Related]
27. [AML stem cell].
Miyamoto T
Rinsho Ketsueki; 2013 Oct; 54(10):1643-50. PubMed ID: 24064813
[No Abstract] [Full Text] [Related]
28. Potential roles for two human homeodomain containing proteins in the proliferation and differentiation of human hematopoietic progenitors.
Kehrl JH; Deguchi Y
Leuk Lymphoma; 1993 Jun; 10(3):173-6. PubMed ID: 8106064
[TBL] [Abstract][Full Text] [Related]
29. The leukemia stem cell.
Estrov Z
Cancer Treat Res; 2010; 145():1-17. PubMed ID: 20306242
[No Abstract] [Full Text] [Related]
30. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
Jafek JL; Shakya A; Tai PY; Ibarra A; Kim H; Maddox J; Chumley J; Spangrude GJ; Miles RR; Kelley TW; Tantin D
Exp Hematol; 2019 Aug; 76():38-48.e2. PubMed ID: 31295506
[TBL] [Abstract][Full Text] [Related]
31. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
[TBL] [Abstract][Full Text] [Related]
32. Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.
Zhang H; Alberich-Jorda M; Amabile G; Yang H; Staber PB; Di Ruscio A; Welner RS; Ebralidze A; Zhang J; Levantini E; Lefebvre V; Valk PJ; Delwel R; Hoogenkamp M; Nerlov C; Cammenga J; Saez B; Scadden DT; Bonifer C; Ye M; Tenen DG
Cancer Cell; 2013 Nov; 24(5):575-88. PubMed ID: 24183681
[TBL] [Abstract][Full Text] [Related]
33. Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML).
Niebuhr B; Iwanski GB; Schwieger M; Roscher S; Stocking C; Cammenga J
Leukemia; 2009 May; 23(5):978-83. PubMed ID: 19020539
[No Abstract] [Full Text] [Related]
34. Mitochondrial carrier homolog 2 is necessary for AML survival.
Khan DH; Mullokandov M; Wu Y; Voisin V; Gronda M; Hurren R; Wang X; MacLean N; Jeyaraju DV; Jitkova Y; Xu GW; Laister R; Seneviratne A; Blatman ZM; Ketela T; Bader GD; Marhon SA; De Carvalho DD; Minden MD; Gross A; Schimmer AD
Blood; 2020 Jul; 136(1):81-92. PubMed ID: 32299104
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia.
Agarwal A; Bolosky WJ; Wilson DB; Eide CA; Olson SB; Fan G; Druker BJ
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24593-24599. PubMed ID: 31754026
[TBL] [Abstract][Full Text] [Related]
36. Integration of cytokine and transcription factor signals in hematopoietic stem cell commitment.
Sarrazin S; Sieweke M
Semin Immunol; 2011 Oct; 23(5):326-34. PubMed ID: 21937237
[TBL] [Abstract][Full Text] [Related]
37. Significance of oncogenes and tumor suppressor genes in AML prognosis.
Kavianpour M; Ahmadzadeh A; Shahrabi S; Saki N
Tumour Biol; 2016 Aug; 37(8):10041-52. PubMed ID: 27179964
[TBL] [Abstract][Full Text] [Related]
38. Seed versus soil: the importance of the target cell for transgenic models of human leukemias.
Westervelt P; Ley TJ
Blood; 1999 Apr; 93(7):2143-8. PubMed ID: 10090920
[No Abstract] [Full Text] [Related]
39. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
Bereshchenko O; Mancini E; Moore S; Bilbao D; Månsson R; Luc S; Grover A; Jacobsen SE; Bryder D; Nerlov C
Cancer Cell; 2009 Nov; 16(5):390-400. PubMed ID: 19878871
[TBL] [Abstract][Full Text] [Related]
40. Leukemia stemness signatures step toward the clinic.
Becker MW; Jordan CT
Cell Stem Cell; 2011 Sep; 9(3):185-6. PubMed ID: 21885015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
